Why the study?
Acetaminophen causes a substantial proportion of acute liver failure, but standard treatment with N-acetylcysteine has limited efficacy in advanced injury or when administered late.
Does moderate intensity static magnetic field treatment reduce mortality and liver damage in mice subjected to high-dose acetaminophen overdose?
Does moderate intensity static magnetic field treatment reduce mortality and liver damage in mice subjected to high-dose acetaminophen overdose?
Moderate intensity static magnetic field treatment offers a novel, non-invasive approach to significantly reduce mortality and mitigate liver damage following acetaminophen overdose in mice.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for static magnetic field adjuncts in acetaminophen hepatotoxicity; should not change practice pending human trials.
Acetaminophen (APAP), the most frequently used mild analgesic and antipyretic drug worldwide, is implicated in causing 46% of all acute liver failures in the USA and between 40% and 70% in Europe. The predominant pharmacological intervention approved for mitigating such overdose is the antioxidant N-acetylcysteine (NAC); however, its efficacy is limited in cases of advanced liver injury or when administered at a late stage. In the current study, we discovered that treatment with a moderate intensity static magnetic field (SMF) notably reduced the mortality rate in mice subjected to high-dose APAP from 40% to 0%, proving effective at both the initial liver injury stage and the subsequent recovery stage. During the early phase of liver injury, SMF markedly reduced APAP-induced oxidative stress, free radicals, and liver damage, resulting in a reduction in multiple oxidative stress markers and an increase in the antioxidant glutathione (GSH). During the later stage of liver recovery, application of vertically downward SMF increased DNA synthesis and hepatocyte proliferation. Moreover, the combination of NAC and SMF significantly mitigated liver damage induced by high-dose APAP and increased liver recovery, even 24 h post overdose, when the effectiveness of NAC alone substantially declines. Overall, this study provides a non-invasive non-pharmaceutical tool that offers dual benefits in the injury and repair stages following APAP overdose. Of note, this tool can work as an alternative to or in combination with NAC to prevent or minimize liver damage induced by APAP, and potentially other toxic overdoses.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: